BNP/CALL/STRYKER CORP./280/0.1/20.12.24 Stock

Warrant

DE000PN38H13

Delayed Deutsche Boerse AG 02:50:29 2024-07-12 pm EDT
6.41 EUR +3.05% Intraday chart for BNP/CALL/STRYKER CORP./280/0.1/20.12.24
Current month-4.89%
1 month-12.27%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 6.41 +3.05%
24-07-11 6.22 +2.13%
24-07-10 6.09 -0.33%
24-07-09 6.11 +2.69%
24-07-08 5.95 -3.88%

Delayed Quote Deutsche Boerse AG

Last update July 12, 2024 at 02:50 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H1
ISINDE000PN38H13
Date issued 2023-06-02
Strike 280 $
Maturity 2024-12-20 (161 Days)
Parity 10 : 1
Emission price 3.84
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.75
Lowest since issue 2.47
Spread 0.05
Spread %0.77%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
338.1 USD
Average target price
372.4 USD
Spread / Average Target
+10.16%
Consensus